Germany Diabetes Devices Market Report 2022 to 2030

Germany Diabetes Devices Market Analysis

$ 3999

The Germany Diabetes Devices Market is expected to witness growth from $832 Mn in 2022 to $1267 Mn in 2030 with a CAGR of 5.40% for the forecasted year 2022-2030. The demand for diabetes devices is being driven by the high and rising incidence of diabetes in Germany. The market is segmented by type and by the end user. Some key players in this market include Rein Medical GmbH, KLS Martin, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.

ID: IN10DEMD007 CATEGORY: Medical Devices GEOGRAPHY: Germany AUTHOR: Jigyasu Bhandari

Buy Now

Germany Diabetes Devices Healthcare Market Executive Analysis

The Germany Diabetes Devices Market is at around $832 Mn in 2022 and is projected to reach $1267 Mn in 2030, exhibiting a CAGR of 5.40% during the forecast period. In 2021, government transfers and rebates paid for all of Germany's current healthcare costs; this represents a rise of $17.37 billion, or 31.5%, from the year before. Because of this, government transfers and subsidies made for 15.7% of the $460.07 billion in current health expenditures, an increase of 3.0% in age points from the previous year.

In Germany, diabetes affected 7.5 million people in 2021. This is equivalent to about 9.2% of the adult population in Germany. Undiagnosed diabetes affects an extra 2.2 million people in Germany. With 590,000 more cases anticipated to be discovered in 2021 alone, diabetes has been on the increase in Germany in recent years. form 2 diabetes is the most common form and accounts for about 95% of all cases in Germany. Type 1 diabetes affects the residual 5% of cases.

In Germany, diabetes devices are medical devices created to aid diabetics in controlling their condition. Blood sugar levels are measured using blood glucose sensors. People with diabetes can check their blood sugar levels at home or while on the go thanks to the typically small size, portability, and ease of use of these devices. This can assist those who have diabetes in managing their condition more effectively by modifying their food, exercise routine, and medication as necessary. Insulin is delivered to the body through a small tube inserted under the skin by insulin pumps, which are portable, wearable devices. Insulin devices help lower the risk of hypoglycemia and can deliver more accurate insulin dosing than injections. Additionally, insulin devices can enhance the quality of life for diabetics by helping them better control their blood sugar levels. Wearable technologies called Continuous Glucose Monitoring (CGM) systems constantly track blood sugar levels all day and all night. Due to the real-time feedback, these devices provide on blood sugar levels, diabetics can modify their diet, exercise routines, and medication as necessary to keep ideal blood sugar control. Additionally, CGM systems can lower the risk of hypoglycemia and enhance overall diabetes control.

Germany Diabetes Devices Market Analysis

Market Dynamics

Market Growth Drivers

Germany is an advanced country with cutting-edge healthcare infrastructure. In comparison to other emerging nations, Germany adopts technologies like continuous glucose monitoring and insulin infusion pumps more quickly. Furthermore, the market is driven and the adoption of new and cutting-edge technologies is increased by the extent to which the pricing and reimbursement policies are controlled. For the players in the German diabetes care device market, some of the market opportunities include the introduction of numerous new products, an increase in international research collaborations for technological advancement, and a rise in diabetes consciousness among the populace. The demand for diabetes devices is being driven by the high and rising incidence of diabetes in Germany. This expands the market for diabetes equipment such as CGM systems, insulin pumps, and blood glucose monitors. Non-invasive diabetes devices that do not call for regular injections or blood tests are preferred by many diabetics. New non-invasive diabetes devices, like continuous glucose tracking systems that do not require fingerstick testing, have been created as a result of this. The market for diabetes devices is evolving as a result of the rising desire for non-invasive devices.

Market Restraints

In Germany, many patients might not be able to purchase diabetes devices because they are frequently expensive. This may reduce consumer interest in these goods and place pressure on suppliers to maintain competitive pricing. Additionally, manufacturers might have to pay expensive expenses for manufacturing, distribution, and R&D, all of which have an effect on their profitability. The market for diabetes devices is extremely competitive in Germany, with both long-standing players and recent entrants competing for market dominance. Manufacturers in the German healthcare market may find it challenging to distinguish their devices and establish a presence in the market as a result.

Competitive Landscape

Key Players

Rein Medical GmbH (DE)
KLS Martin (DE)
Johnson & Johnson
Medtronic
Roche
Dexcom
Ascensia Diabetes Care

Healthcare Policies and Regulatory Landscape

The German Federal Institute for Drugs and Medical Devices (BfArM) has strict regulations regarding the sale of diabetes equipment in Germany. To get their goods approved, manufacturers must adhere to rigid regulatory standards for quality, performance, and safety. Health technology assessments (HTAs) are performed by the German Federal Joint Committee (G-BA) to measure the efficacy and value of medical devices. To back up their goods and show that they are worth the money, manufacturers must offer solid clinical proof. The German government has made sizable investments in telemedicine and mobile health applications, among other digital health technologies. To stay competitive, producers must adjust to the evolving state of digital health and integrate digital technologies into their offerings. In order to reduce expenses for patients and the healthcare system, the German government places price controls on medical equipment. In order to guarantee that their products are priced competitively, manufacturers must navigate these price controls.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Diabetes Devices Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into blood glucose monitoring systems, insulin delivery systems, and mobile applications for managing diabetes within the type segment. Due to its convenience, ease of use, and usefulness in providing patients and healthcare professionals with real-time insights regarding diabetic conditions for integrated diabetes management, the segment for diabetes management mobile applications is anticipated to grow at the highest rate during the forecast period. Bare-metal Stents

Blood glucose monitoring systems
Self-monitoring blood glucose monitoring systems
Continuous glucose monitoring systems
Test strips/Test papers
Lancets/Lancing Devices
Insulin delivery Devices
Insulin pumps
Insulin pens
Insulin syringes and needles
Diabetes management mobile applications

By End User (Revenue, USD Billion):

The diabetes market is divided into hospitals & specialty clinics and self & home care, based on the end user.

Hospitals & Specialty Clinics
Self & Home Care

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.